Dexmethylphenidate Hydrochloride: Clinical Trials

6 trials of Dexmethylphenidate Hydrochloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 22Completed 2

Follow Dexmethylphenidate Hydrochloride: new trials by email Literature Review of Dexmethylphenidate Hydrochloride trials Research Report on Dexmethylphenidate Hydrochloride

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)
Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State
Phase 1CompletedCingulate Therapeutics252024-10-312025-08-12
Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects
Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State
Phase 1CompletedCingulate Therapeutics272022-09-142022-10-20
CTx-1301 Comparative Bioavailability Study
Dexmethylphenidate 5 Mg Oral Capsule, Extended Release, Dexmethylphenidate 6.25 mg Tablet, Dexmethylphenidate 40 Mg Oral Capsule, Extended Release - ADHD
Phase 1 / Phase 2CompletedCingulate Therapeutics452019-12-062021-04-08
Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate
dex-methylphenidate - Drug Binding to DAT Receptors
Phase 1 / Phase 2CompletedMassachusetts General Hospital232006-12-012013-10-22
Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions
Dexmethylphenidate Hydrochloride - Healthy
Phase 1CompletedTeva Pharmaceuticals USA242004-06-012024-08-19
Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions
Dexmethylphenidate Hydrochloride - Healthy
Phase 1CompletedTeva Pharmaceuticals USA242004-06-012024-08-19

Conditions studied

Fasting (2)  ·  Attention Deficit Disorder with Hyperactivity (1)

Sponsors

Cingulate Therapeutics (3)  ·  Teva Pharmaceuticals USA (2)  ·  Massachusetts General Hospital (1)

Countries

United States (6)

Top investigators

Matt Brams, MD (3)  ·  Irwin Plisco, M.D. (2)  ·  Thomas Spencer, MD (1)

Results publications

PMID 22154896, PMID 42518155